BDBM590886 4-hydroxy-N-((1s,4s)-4-methylcyclohexyl)- 1-(2-morpholinoethyl)-2-oxo-1,2-dihydro- 1,8-naphthyridine-3-carboxamide::US11564928, Compound 137

SMILES C[C@H]1CC[C@H](CC1)NC(=O)c1c(O)c2cccnc2n(CCN2CCOCC2)c1=O

InChI Key InChIKey=JJXFSLXZUQOSJB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590886   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590886(US11564928, Compound 137 | 4-hydroxy-N-((1s,4s)-4-...)
Affinity DataIC50: 15nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590886(US11564928, Compound 137 | 4-hydroxy-N-((1s,4s)-4-...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent